Morcellators are class II medical devices used during laparoscopic procedures. The device cuts tissues into smaller pieces, which can be removed with the help of laparoscopes. Morcellation is a minimally invasive surgery which allows surgeons to perform various surgeries with a small incision, reducing the recovery time. The procedure is considered to be an alternative to traditional invasive abdominal surgery, and is designed to facilitate large tissue removal through a small incision. Rather than opening up the abdomen and making large cuts into the muscular area, surgeons prefer morcellation during hysterectomy and laparoscopic procedures to speed up the recovery time, and eliminate pain & post-surgical complications.

Read Report Summary: https://www.transparencymarketresearch.com/morcellators-market.html

Rise in preference for minimally invasive gynecological and other surgical procedures, and increase in awareness among the population about advanced surgical tools are the major factors likely to boost the growth of the morcellators market during the forecast period. The U.S. FDA issued warning and restrictions for the use of morcellators in 2014, estimating that one in every 350 women undergoing a hysterectomy with a power morcellator are diagnosed with some undetected leiomyosarcoma cells. Due to the demonstrated risk of spread of cancer in women undergoing hysterectomy using morcellator, the FDA recommended that morcellators should no longer be used during myomectomy or hysterectomy. This is expected to restrain the global morcellators market from 2018 to 2026.

The global morcellators market can be segmented based on product type, application, and end-user. In terms of product type, the market can be bifurcated into manual morcellators and power morcellators. The power morcellators segment can be divided into laparoscopic morcellators and hysteroscopy morcellators. The power morcellators segment accounted for the largest market share in terms of revenue in 2017, attributed to the faster recovery time associated with surgeries done with power morcellators and rise in patient pool for hysterectomy procedures. However, small clumps of cancerous tissues could be left behind in the abdominal cavity after the use of power morcellators, which can result in the cancer spreading to otherwise healthy tissues.

For a broader view of the competition landscape, Request for the Report Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=45060

This factor is expected to hamper the growth of the power morcellators segment during the forecast period. Based on application, the market can be classified into uterine fibroids, hysteroscopy, laparoscopy, and others. The hysteroscopy segment accounted for the largest market share in 2017, owing to increase in number of women undergoing hysteroscopy procedures and technological advancements in the surgical tools. The uterine fibroids segment has witnessed significant growth in the past few years due to increase in usage of morcellators in the removal of cancerous tissues. In terms of end-user, the global morcellators market can be categorized into hospitals, ambulatory surgical centers, clinics, and others. The hospitals segment is expected to dominate the market during the forecast period due to the availability of well-qualified and trained health care professionals in hospitals and improved reimbursement policies of multispecialty hospitals.

Geographically, the global morcellators market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest market share in 2017. The market in the region is driven by increase in investments in the health care sector, and strategic presence of key companies in the U.S. and Canada. The region is anticipated to lead the market during the forecast period due to rise in awareness among the population about technological advancements in surgical tools, and increase in preference for minimally invasive surgical procedures. Attempts being made by companies to overcome the spread of cancer due to usage of power morcellators is likely to boost the growth of the market in Asia Pacific during the forecast period.

Inquire for the Discount on the Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=45060

Major players in the global morcellators market are Medtronic, Stryker Corporation, Johnson & Johnson Services, Inc. (Ethicon, Inc.), Karl Storz GmbH & Co., C. R. Bard, Inc., Olympus Corporation, and Cook Urological, Inc., among others.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to industry leaders, consultants, and strategy professionals.

Our reports are single-point solutions for industries to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These demands are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for client-specific problems with right methodology of research is the key to help enterprises reach right decision.

U.S. Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com